BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies |
||||
Company |
Ticker
|
Current Price
(April 26, 2005) |
Last Price
(April 19, 2005) |
% Change
|
Agilent |
A
|
21.34
|
20.77
|
2.74
|
Applied Biosystems
|
ABI
|
20.19
|
20.28
|
-0.44
|
BD |
BDX
|
56.55
|
56.71
|
-0.28
|
Beckman |
BEC
|
66.34
|
66.29
|
0.08
|
Bio-Rad |
BIO
|
49.21
|
50.06
|
-1.70
|
Bruker |
BRKR
|
3.16
|
3.4
|
-7.06
|
GE |
GE
|
36.18
|
36
|
0.50
|
Harvard Bio |
HBIO
|
3.8
|
3.65
|
4.11
|
Invitrogen |
IVGN
|
73.51
|
70.93
|
3.64
|
Molecular Devices |
MDCC
|
18.6
|
19.54
|
-4.81
|
PerkinElmer |
PKI
|
19.87
|
19.6
|
1.38
|
Sigma |
SIAL
|
57.6
|
58.49
|
-1.52
|
Stratagene |
STGN
|
8.11
|
8.01
|
1.25
|
Thermo |
TMO
|
25.21
|
24.77
|
1.78
|
Waters |
WAT
|
39
|
34.87
|
11.84
|
Index Average |
|
33.24
|
32.89
|
1.04
|
Waters Shares Gain 12 Percent as Index Rebounds
In advance of its earnings report this week, Waters shares soared and the company regained approximately $384 million of the $1.2 billion in market share it lost in early April when it revised its earnings and revenue forecast downwards.
Waters shares closed up 12 percent to $39 for the five-day period ending Tuesday to lead the multiplatform molecular biology tools companies whose shares are tracked in the BioCommerce Week index. Waters this week reported 3-percent growth in revenues for its first quarter (see related story).
Overall, the BCW index closed up for only the second time in the last seven weeks, ending the period up 1 percent at $33.24 and outperforming the major stock-market indices. The Dow Jones Index and the S&P 500 finished even for the five-day period after rallying from a 2 percent retreat last week, while the Nasdaq was down approximately 0.75 percent. The Amex pharma index fell nearly 1 percent.